J Clin Neurol. 2021 Oct;17(4):576-578. English.
Published online Sep 17, 2021.
Copyright © 2021 Korean Neurological Association
Brief Communication

Cervical Cord Hemorrhage in Cerebral Cavernous Malformations

Zhanjun Wang,a Hao Wu,b Yueshan Piao,c and Chaodong Wanga
    • aDepartment of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
    • bDepartment of Neurosurgery, Xuanwu Hospital of Capital Medical University, Beijing, China.
    • cDepartment of Pathology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Received March 24, 2021; Revised June 18, 2021; Accepted June 21, 2021.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Dear Editor,

Cavernous malformations are vascular malformations of the central nervous system, with the lesions comprising clusters of abnormal small blood vessels that are mostly detected intracranially. Mutations in KRIT1, CCM2, and PDCD10 have been found to cause cerebral cavernous malformations (CCMs). CCM proteins can bind different molecules such as scaffolding proteins and kinases, and form a CCM signaling complex (CSC). Mutant CCM proteins impair the function of the CSC and cause endothelial barrier dysfunction and hyperpermeable blood vessels.1 Twenty percent of CCMs are familial cases with an autosomal dominant pattern, with incomplete penetrance and variable expressivity. Mutations in KRIT1, CCM2, and PDCD10 account for 50%, 20%, and 10% of familial cases, respectively.1 Most cases with widespread lesions are hereditary, and cases with isolated lesions may exhibit mosaicism.2 The clinical presentation varies with the location, number, and size of the lesions. Recurrent hemorrhage in the lesions causes neurological deficits in CCMs patients.

Intramedullary spinal cavernous malformations (ISCMs) are rare, accounting for 5–12% of all intraspinal vascular malformations.3 However, the prevalence of ISCMs is high (about 70%) in cases of familial CCMs and is positively correlated with the age at onset and number of lesions.4 Here we report on a case of ISCMs presenting with hemiplegia, including providing imaging, pathological, and genetic data.

A 62-year-old female complained of numbness and a paroxysmal sense of discharge, weakness in the upper left limb for 8 months, and progressive weakness in the lower left limb for 4 months. Pain in the waist had resulted in schwannoma of the left lumbar nerve root being diagnosed 4 years previously. Resection of the schwannoma produced the sequela of numbness in her left lower limb. At the current presentation, a neurological examination revealed that the strength of the left upper limb was Medical Research Council scale (MRC) grade 3/4, with distal muscles more severely affected than proximal muscles. The strength of the left lower limb was MRC grade 4. The strength of the right extremities was normal, and ataxia was not found. Analgesia was revealed in the upper left limb. Hypesthesia was found below the left knee, which was presumed to be a remnant sign from the schwannoma resection in the lumbar nerve root 4 years previously. Her proprioception was normal. Tendon reflexes were active except for Achilles reflexes. Hoffman and Babinski signs were positive bilaterally, and more prominent in the left. Brain susceptibility-weighted MRI showed diffused lesions consistent with CCMs in the cerebral hemispheres, cerebellum, and brain stem (Fig. 1A–C). A physical examination indicated the damage of the cervical spinal cord, and so we performed the cervical MRI, which revealed oval intramedullary mixed signals (about 0.9 cm × 0.7 cm × 1.9 cm), predominantly on the left side at the fifth cervical vertebra level (Fig. 1D–F). Whole-exome sequencing identified that the patient carried a mutation in KRIT1, which was confirmed by Sanger sequencing. No mutation was detected in either CCM2 or PDCD10. Combined with the genetic analysis, CCMs caused by a known KRIT1 mutation (c.1362_1363delTC; p.Gln455ArgfsTer24) was diagnosed.5

Fig. 1
1. MRI of the brain and the cervical spinal cord, as well as the pathological findings. A–C: Susceptibility-weighted images revealed numerous lesions of different sizes consistent with cerebral cavernous malformations in the cerebral hemispheres, cerebellum, and brain stem. D: Sagittal T1-weighted images of the cervical spinal cord revealed a hyperintense lesion at the fifth cervical vertebra level. E: Sagittal T2-weighted images revealed a heterogeneous hyperintense lesion with a hypointense rim. F: Axial T2-weighted images of the cervical spinal cord contained intramedullary mixed signals of an oval shape surrounded by circular hypointense signals, predominantly on the left side. G–I: Sagittal T1-weighted images (G), sagittal T2-weighted images (H), and axial T2-weighted images (I) of the cervical spinal cord revealed postoperative changes at the 6-month follow-up. J: A blue-purple intramedullary mass under the pia mater was exposed during the operation. K: The intramedullary mass was totally resected. L: A histopathological examination showed hyperplasia of vessels, which had thin vascular walls and thrombosis, accompanied with gliosis and fresh and old hemorrhages (hematoxylin-eosin; scale bar=200 µm).

Some CCMs patients are asymptomatic, whereas our patient exhibited hemicervical spinal cord syndrome and progressive hemiplegia, supporting the diagnosis of ISCMs. Due to the recurrent hemorrhage signals in cervical MRI being larger than 1 cm and the presence of progressive hemiplegic symptoms, the ISCMs were resected. An intramedullary blue-purple vascular mass (Fig. 1J) was resected in its entirety (Fig. 1K). Its pathology suggested that it was hyperplastic vascular tissue from the thin vascular wall, and a local thrombosis with fresh and stale bleeding accompanied with glial cell proliferation were observed (Fig. 1L). Six weeks after the operation, the grip strength of her left hand was improved, and the weakness of her left lower limb was not aggravated.

Cervical MRI performed at a 6-month follow-up visit showed postoperative changes of ISCMs (Fig. 1G–I), and the left limb weakness remained. The brain MRI findings were normal for her two daughters, who were negative for the KRIT1 mutation.

This case presented with progressive numbness and weakness of the left limbs, and cerebrovascular disease or cervical spondylopathy was suspected initially. However, cervical MRI revealed a mixed lesion of fresh and old intramedullary hemorrhage. The mutation identified in KRIT1 further supported the diagnosis of ISCMs. In view of the large cervical lesion and progressive neurological deficit in the patient and the low risk of subsequent hemorrhage after ISCMs resection,6 ISCMs resection was performed. This case provides a precision medicine demonstration of ISCMs.

Notes

Ethics Statement:This study has been approved by the Ethics Committee of the Xuanwu Hospital of Capital Medical University (No. 2021[034]). Informed consent for genetic testing and publication of photo graphs has been obtained from the patient.

Author Contributions:

  • Conceptualization: Zhanjun Wang, Chaodong Wang.

  • Investigation: Zhanjun Wang, Hao Wu, Yueshan Piao.

  • Methodology: Zhanjun Wang, Hao Wu, Yueshan Piao.

  • Supervision: Chaodong Wang.

  • Validation: Zhanjun Wang, Hao Wu, Yueshan Piao.

  • Visualization: Zhanjun Wang, Hao Wu, Yueshan Piao.

  • Writing—original draft: Zhanjun Wang.

  • Writing—review & editing: Chaodong Wang, Zhanjun Wang.

Conflicts of Interest:The authors have no potential conflicts of interest to disclose.

Funding Statement:This study was supported by the grants from Ministry of Science and Technology (2016YFC1306000), Special Fund from Key laboratory of Neurodegenerative Diseases, Ministry of Education of China (PXM2019_026283_000002), National Natural Science Foundation (81771212) and Beijing Municipal Science & Technology Commission (Brain Science Projects, Z161100000216140) to Dr. Chaodong Wang.

Availability of Data and Material

The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.

Acknowledgements

We sincerely thank all of the individuals who participated in this study.

References

    1. Riolo G, Ricci C, Battistini S. Molecular genetic features of cerebral cavernous malformations (CCM) patients: an overall view from genes to endothelial cells. Cells 2021;10:704
    1. Rath M, Pagenstecher A, Hoischen A, Felbor U. Postzygotic mosaicism in cerebral cavernous malformation. J Med Genet 2020;57:212–216.
    1. Gross BA, Du R, Popp AJ, Day AL. Intramedullary spinal cord cavernous malformations. Neurosurg Focus 2010;29:E14
    1. Mabray MC, Starcevich J, Hallstrom J, Robinson M, Bartlett M, Nelson J, et al. High prevalence of spinal cord cavernous malformations in the familial cerebral cavernous malformations type 1 cohort. AJNR Am J Neuroradiol 2020;41:1126–1130.
    1. Hartmann K, Stein KP, Neyazi B, Felbor U, Hethey S, Sandalcioglu IE. CCM1/KRIT1 mutation in monozygotic twins of a polyzygotic triplet birth: genetic, clinical and radiological characteristics. Neurosurg Rev 2019;42:765–768.
    1. Zhang L, Yang W, Jia W, Kong D, Yang J, Wang G, et al. Comparison of outcome between surgical and conservative management of symptomatic spinal cord cavernous malformations. Neurosurgery 2016;78:552–561.

Metrics
Share
Figures

1 / 1

PERMALINK